Roche appoints Lyon VP and Nutley site head
This article was originally published in Scrip
Roche has appointed Tom Lyon vice-president and site head at the Nutley, New Jersey facility, replacing Ivor Macleod. Previously, Mr Lyon served as vice-president of site services for Genentech, a member of the Roche Group.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.